Mutations that disrupt the gene BRCA2 dramatically increase the odds of developing breast and ovarian cancer—but such mutations aren’t enough to cause cancer on their own. To turn normal cells cancerous, some of BRCA2’s genetic interactors must also mutate. In an article recently published in GENETICS, Ding et al. sought to identify some of these genes.

BRCA2 is a tumor suppressor gene that normally helps cells maintain genome integrity, which is why its loss can lead to mutations in other genes and eventually to cancer. But losing BRCA2 function also cripples a cell’s ability to proliferate—making cancer less likely to develop, not more. One possible explanation for this seeming contradiction is that additional mutations in other genes allow cells without functional BRCA2 to survive and become dangerous.

To find such genetic interactors, the researchers screened a mouse cell line in which disabling both copies of the mouse version of BRCA2 (Brca2) is lethal, enabling them to look for genetic changes that would allow cells with no functional Brca2 to survive. Their screen turned up Gipc3, which was not known to be involved with Brca2 or breast cancer; it was instead associated with certain types of deafness.

Gipc3 doesn’t simply compensate for Brca2 mutants’ defects in DNA repair. The researchers observed that, although overexpressing Gipc3 allowed cells to survive without functional Brca2, it wasn’t enough to protect them from DNA-breaking ionizing radiation. This made the group suspect that other genes are also involved.

Ding et al. looked for proteins that bind the protein encoded by Gipc3 (GIPC3), collecting proteins that physically associate with GIPC3 and using mass spectrometry to identify them. They found that signaling proteins APPL1 and APPL2 appear to bind GIPC3, but the analysis couldn’t show for certain that they’re involved in the pathway of interest. Using existing structural data, they predicted which parts of GIPC3 may be important for binding APPL1 and APPL2, reasoning that if they could disrupt these interactions, they could see whether the two proteins worked with GIPC3 to allow cells without functional Brca2 to survive.

They found that when APPL1 and APPL2 are unable to properly bind GIPC3, most cells don’t survive Brca2 loss, indicating that APPL1 and APPL2 are critical for GIPC3’s role in protecting these cells. APPL1 and APPL2 have many functions in the cell, and it’s unclear how they work with GIPC3, which is a topic for future study. This work adds Gipc3 to a growing list of genetic Brca2 interactors that may play a role in development of breast and ovarian cancer, adding another fragment to the complex genetic story of how ordinary cells become cancerous.

CITATION:

Ding, X.; Philip, S.; Martin, B.; Pang, Y.; Burkett, S.; Swing, D.; Pamala, C.; Ritt, D.; Zhou, M.; Morrison, D.; Ji, X.; Sharan, S. Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2.
GENETICS, 207(4), 1335-1345.
DOI: 10.1534/genetics.117.30035
http://www.genetics.org/content/207/4/1335

, , ,

Nicole Haloupek is a freelance science writer and a recent graduate of UC Berkeley's molecular and cell biology PhD program.

View all posts by Nicole Haloupek »

Read more in

  • Ed Grell at his dissecting microscope using ether to anesthetize his flies.

    In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation

    Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…

  • Congratulations to the #Fungal24 Poster Award winners!

    We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…

  • Poster presentation tips for TAGC 2024

    You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…

  • Maximize your TAGC 2024 experience 

    A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…

  • Early Career Leadership Spotlight: Sarah Petrosky

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…

  • TAGC 2024 Early Career Award Winners

    GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024.  Don’t miss the opportunity…

  • Preeminent geneticists recognized with revamped GSA Awards

    In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…

  • Fly Board funds outreach programs to spread the word about Drosophila research

    In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…

  • New members of the GSA Board of Directors: 2024–2026

    We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…

  • A rose-ringed parakeet, one of three parrot species used in the study.

    Parrot plumage study aids breeders and endangered natural populations

    Yellow coloration is maladaptive in the wild but prized by breeders. People have long been fascinated with birds, which exhibit one of the widest ranges of coloration among vertebrates. Parrots, in particular, have captivated humans by their ability to mimic human speech and spectacular plumage. Brightly colored feathers are used primarily to attract mates, intimidate…

  • Early Career Leadership Spotlight: Sarah Gilmour

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah GilmourMultimedia SubcommitteeStowers Institute for Medical Research Research Interest Questions of evolution have always fascinated me. I am extremely fortunate to be starting out my research career in a…